CMBA
PRAH

C.M. Bidwell & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History

C.M. Bidwell & Associates’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-465
Closed -$52K – 494
2019
Q4 		$52K Buy
+465
New +$47.8K 0.05% 230
2018
Q1 		– Sell
-5,025
Closed -$458K – 456
2017
Q4 		$458K Buy
+5,025
New +$418K 0.4% 62

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

C.M. Bidwell & Associates's PRAH Position: Q1 2020 in Review

C.M. Bidwell & Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 465 shares — an estimated $52K sold.

C.M. Bidwell & Associates first reported a position in PRAH in Q4 2017 and held it in 2 quarters. The position peaked at $458K in Q4 2017. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • C.M. Bidwell & Associates reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 465 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $52K.
  • C.M. Bidwell & Associates first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 2 quarters.
  • C.M. Bidwell & Associates's PRA Health Sciences, Inc. position peaked at $458K in Q4 2017.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2020, filed 15 May 2020.